In Africa, pregnant women and young children are the most vulnerable to malaria.

However, malaria control interventions and strategies have achivied important results in the last years.

COVID-19 has now made these interventions critical, and could undo the results obtained so far, as highlighted by scientists in the Lancet: https://bit.ly/2Tfyxwn.

Potentially, COVID-19 could indirectly cause more deaths than it already does directly, in the context of Africa’s weak and fragile health systems.

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

From 2003 at the forefront of supporting Sub-Saharan Africa’s response to poverty-related infectious diseases, EDCTP plays a key role also in the African response to Covid-19

The European & Developing Countries Clinical Trials Partnership (EDCTP) is a public-public partnership between countries in Europe and sub-Saharan Africa, supported by the European Union, which since 2003 has been

Exemplary coordination of African researchers and scientists

Exemplary coordination of African researchers and scientists involved in the response to the pandemic to study treatments that prevent serious complications of COVID-19 https://bit.ly/37SvaCz

Ebola outbreak in Republic Democratic of the Congo: switching from MEURI (Monitored Emergency Use of Unregistered and Investigational Interventions) to a RCT (Randomized Clinical Trial) for 4 experimental medications in the treatment of Ebola Virus Disease

An international research team has begun patient enrollment in a clinical trial testing multiple investigational Ebola therapies in the Democratic Republic of the Congo (DRC). The randomized, controlled trial is